India's Sun Pharma aims to launch its obesity drug in five years, managing director says
India's largest drugmaker by revenue Sun Pharmaceutical is aiming to launch its experimental anti-obesity and type 2 diabetes ...
Sun Pharma aims to launch anti-obesity and type 2 diabetes drug Utreglutide in five years: Dilip Shanghvi
Sun Pharmaceutical, India's largest drugmaker by revenue, plans to launch its experimental anti-obesity and type 2 diabetes ...
Hollywood plastic surgeons spill on new Ozempic hack A-listers used for speedy Oscars makeovers... and why 'you'll be shocked' to discover who's doing it!
For Oscars 2025, there's a new trend in town: microdosing, taking tiny amounts of Ozempic and other weight-loss jabs is the ...
Where Will Eli Lilly Be in 5 Years?
It's hard to argue with the kinds of results Eli Lilly (NYSE: LLY) has produced over the past five years. Let's figure out ...